Peptonic Medical

Item 11 - Election of board members and any deputy board members

The nomination committee proposes that Anders Blom, Jacob Eriksson, Daniel Rudeklint, and Tarek Shoeb, be re-elected as board members for the period until the end of the next annual general meeting. Anders Blom is proposed for re-election as chairman of the board.

For further information, please contact:
Anna Linton, CEO, Peptonic Medical AB
Email: anna.linton@peptonicmedical.se                             
Phone: +46 70-244 92 07

About Peptonic Medical AB                                                                                                       
PEPTONIC medical AB (publ) is a pioneering Swedish medtech company specializing in the development and sale of clinically proven self-care products for women's intimate health. Through its brands VagiVital and Vernivia, the Company offers a broad over-the-counter portfolio of effective and gentle products designed to help women understand, treat, and prevent common medical conditions in the intimate area. Peptonic's growth strategy centers on geographic expansion, particularly in the U.S. and Europe, while continually enhancing its product portfolio through in-house development and strategic acquisitions.

The Company is headquartered in Stockholm, Sweden, and operates the subsidiaries, Peptonic Medical Inc. and Common Sense Marketing Inc., in the U.S. Peptonic Medical was founded in 2009 and has been listed on the Spotlight Stock Market since 2014.